| Also known as |
Rapamycin |
| Blood pressure |
Can cause hypertension |
| Chemical name |
Rapamycin |
| Dosage (medical) |
Initially 6 mg, followed by 2 mg daily |
| Dosage (sports) |
Not applicable |
| Effects |
Immunosuppressive, anti-proliferative |
| Formula |
C51H79NO13 |
| Half-life |
Approximately 62 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Monitoring of sirolimus blood levels |
| Main action |
Inhibits T-cell activation and proliferation |
| Side effects |
Increased risk of infections, anemia, hyperlipidemia, thrombocytopenia, interstitial lung disease |
| Storage conditions |
Store at room temperature away from moisture and light |
| Strength |
1 mg |
| Substance class |
Macrolide immunosuppressant |
| Trade name |
Rapamune |
| Use in sports |
None |
| Water Retention |
Minimal |
| Manufacturer |
Pharmaceutical |
